All Type of News
YD Life Science acquires approval of DR therapy for Phase 2a clinical trial in U.S.
YD Life Science(CEO Jin-Woo Lee) announced on the 21st that its diabetic retinopathy(DR) therapy ‘YD-312’ acquired final approval for a Phase 2a clinical trial from the U.S. Food and Drug Administration.
Diabetic ret...
Patent Court gives decision in favor of Layla generics, nullifying its composition patent
The composition patent of ‘Layla(PMG Pharm),’ a natural drug for osteoarthritis making approximately KRW 20 billion sales, received a decision of nullification at the Patent Court.
Mother’s Pharm led the nullificatio...
Celltrion Group Chairman Jung-Jin Seo starts to manage overseas businesses
Celltrion Group Chairman Jung-Jin Seo are visiting partnering companies in about 40 countries, and is discussing detailed business strategies about its products with CEOs and directors.
According to Celltrion Group, ...
In H&B market, Olive Young is closely chased by Lalavla, LOHB’s and BOOTS
In the H&B(Health and Beauty) store market which formed about KRW 1.7 trillion last year, large companies, such as Olive Young, Lalavla, LOHB’s and BOOTS, are competing fiercely each other.
CJ OliveNetworks’ Olive Yo...
KPBMA conducting check-up before the pharma industry job fair
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) is conducting a preliminary check-up on its member companies about details of their second half recruiting plan, such as number of people to rec...
Kolon Pharma signs KRW 14 billion co-promotion with Abbott Korea
Kolon Pharma(CEO Woo-Seok Lee) announced on the 20th that they signed a co-promotion agreement for 5 products including Klaricid Film Coated Film with Abbott Laboratories.
The agreed products are Klaricid Film Coated...
GC Pharm starts to ship flue vaccines for this season in Korea
Influenza(flu) vaccines have started to be shipped.
GC Pharm(CEO Eun-Cheol Huh) announced on the 20th that they have started to ship the 2018-2019 seasonal trivalent and tetravalent vaccines ‘GCFlu Prefilled Syringe ...
Unimed Pharm passes U.S. FDA’s onsite inspection for disposable artificial tears
A eye drop company Unimed Pharm(CEO Gun-Nam Kim) announced on the 20th that they successfully passed the U.S. FDA onsite inspection recently for the disposable eye drop ‘Carboxymethylcellulose sodium 0.5%.’
The compa...
Daewoong’s Nabota enters advanced market with Canadian approval
Daewoong Pharmaceutical’s Nabota has finally opened a new pharmaceutically advanced market.
Daewoong Pharmaceutical(CEO Seung-Ho Jeon) announced its self-developed botulinum toxin product ‘Nabota’ was approved from t...
One of 5 listed pharmas spending more than 10% of their sales into R&D
Listed pharmaceutical companies have been criticized to pay no attention in making investment into R&D.
Yakup Shinmoon(www.yakup.com) analyzed KOSPI and KOSDAQ listed pharmaceutical companies’ 2018 first half busines...
